“ NARL ”---- Nor Adrenaline ReLease ( Noradrenaline is well-known as hormone to induce lipolysis and be released in the body)
“NARL”is a trade-mark for the company’s products. The emission of NARL ultrasounds at a frequency of 517 KHZ coupled with an intensity of 110mW/ stimulates the sympathetic nerve terminals that induces to release Noradrenaline without instructions from the brain, most efficiently. This principle was discovered and scientifically proven to be extremely effective for natural lipolysis by Dr. Hirohide Miwa who is a founder of the company, under co-research with universities and medical institutions.
NARL ultrasound is internationally patented in Japan, U.S.A., China, Korea, Canada and presently, in process for Europe, Brazil, etc.
NARL ultrasound’s safety is satisfied with the norms of  U.S. FDA (Food & Drug Administration, U.S.A.) .

Research & Development for “NARL ultrasound

The research and development for NARL ultrasound was cooperated by 6 Universities and 3 Medical Institutions.
The efficiency of NARL ultrasound was scientifically proved, through the basic research and the extensive examinations for the practical use, by the organization.

International Patent

Granted : Japan U.S.A. China Canada
In process of registration : Europe Brazil